 |
Fully human IgG1 antibody specific for CD33 |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Rd., PO Box 368;Ridgefield, Connecticut, 06877 |
